Company Filing History:
Years Active: 2006-2025
Title: Innovator Jie Du: Pioneering Treatments for Acute Urticaria
Introduction
Jie Du, based in Lansdale, PA, is an accomplished inventor with a remarkable portfolio of 12 patents. His work primarily focuses on innovative methods for treating acute urticaria, showcasing his commitment to advancing medical treatments and improving patient care.
Latest Patents
Among Jie Du's noteworthy inventions is the development of a dosing regimen for injectable cetirizine. This patent describes a method of administering injectable cetirizine or levocetirizine to effectively treat acute urticaria, including cases accompanied by angioedema. The method emphasizes the importance of administering the treatment quickly in an emergency setting, allowing for a therapeutically effective solution that can be crucial for patients experiencing severe symptoms.
In another significant patent, Jie Du elaborates on administering injectable cetirizine or levocetirizine by intravenously injecting patients with a maximum daily dose no more than 15 times the recommended clinical daily dose for the mammal. This tailored approach is designed to maximize therapeutic outcomes while ensuring patient safety.
Career Highlights
Jie Du has made significant contributions to the field of pharmaceuticals through his work with companies such as JDP Therapeutics, Inc. and Mutual Pharmaceutical Company, Inc. His innovative contributions reflect both his expertise in pharmacology and his dedication to formulating effective therapies for pressing medical issues.
Collaborations
Throughout his career, Jie Du has collaborated with notable colleagues, including Richard H. Roberts and Matthew William Davis. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.
Conclusion
Jie Du's innovative spirit and commitment to enhancing medical treatment for acute urticaria is evident through his impressive range of patents. His work not only demonstrates the potential of injectable cetirizine and levocetirizine but also leaves a lasting impact on patient care practices in emergency settings. As he continues to innovate, Jie Du remains a pivotal figure in the realm of pharmaceutical advancements.